Healthy: Clinical Trials

306 trials for Healthy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

246 completed, 18 unknown, 17 terminated, 12 recruiting. 306 Phase 2, 108 Phase 1, 19 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2306Completed 246, Unknown 18, Terminated 17, Recruiting 12, Withdrawn 4, Active not recruiting 3, Enrolling by invitation 3, Not yet recruiting 3
Phase 1108Completed 84, Unknown 9, Recruiting 7, Terminated 4, Not yet recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 319Completed 17, Unknown 2

Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy

Trials (filtered) newest first · largest first

All 306 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Psilocybin, Pimavanserin, Inactive Placebo - Mood (Psychological Function), Well Being
Phase 1 / Phase 2RecruitingJohns Hopkins University202026-10-292026-11-02
A Study of Single and Combination Lipase Dietary Supplements to Increase Fatty Acid Absorption in Generally Health Adults
THRIVE4U™ TG Lipase, THRIVE4U™ Spectrum Lipases, Placebo - Digestive Symptoms, Gastrointestinal Symptoms
Phase 1 / Phase 2Not yet recruitingDanisco502026-10-012026-10-23
The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function
Placebo, Psilocybin 15mg - Healthy
Phase 1 / Phase 2Not yet recruitingManoj Doss482026-09-012026-06-15
Assessing Covert Consciousness During Dexmedetomidine and Ketamine Sedation: An fMRI Study
Dexmedetomidine (+propofol as indicated), Ketamine - Healthy, Covert Consciousness
Phase 2Enrolling by invitationUniversity of Michigan602026-08-072026-08-11
A Clinical Study of V540A in Healthy Female Participants (V540A-005)
V540A-2, V540A-3, GARDASIL®9 - Healthy
Phase 2WithdrawnMerck Sharp & Dohme LLC2026-07-202026-09-14
Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term Travel
Placebo, Probiotic - Healthy
Phase 2Not yet recruitingMin-Tze LIONG602026-07-012026-07-09
Naturally Produced Cannabinoids for Neuroprotection From Concussion
Broad spectrum cannabinoid formulation, Placebo gel capsule - Healthy
Phase 2RecruitingUniversity of Regina602026-06-012026-07-21
Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
Fisetin, Placebo - Multimorbidity, Healthy
Phase 1 / Phase 2RecruitingOve Andersen602026-03-242026-05-19
Assessing the Safety of an IGY Supplement on the Gut Microbiome
IgY supplement, Placebo - Healthy, Microbiome
Phase 1 / Phase 2WithdrawnNimble Science Ltd.2026-01-012026-09-30
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
Everolimus, Placebo, Resistance training - Healthy, Osteopenia
Phase 2RecruitingOdense University Hospital1482025-10-202026-04-06
Propolis-Based Solution Application in Extraction Socket Healing
Propolis-based topical solution (52% propolis extract, clove oil [Eugenia caryophyllus], and white willow bark [Salix alba] extract), Saline rinse (control) - Healthy
Phase 1 / Phase 2CompletedSaint-Joseph University142025-10-012026-06-29
A Study of SJP-001 in Comparison With Fexofenadine and Naproxen Administered With Alcohol
Treatment A- Fexofenadine HCl 60mg, Treatment B- Naproxen sodium 220mg, Treatment C- SJP-001 280mg - Healthy
Phase 1 / Phase 2CompletedSen-Jam Pharmaceutical472025-09-302026-03-23
Topical Menthol For Tear Secretion
Topical application of 20% menthol solution in MCT oil., Topical Placebo Oil rolled onto the cheek. - Healthy, Dry Eyes
Phase 2Enrolling by invitationReinhold Vieth302025-08-172025-09-16
A Study of LY3549492 in Healthy Weight Adult Participants
LY3549492, Placebo - Healthy
Phase 2TerminatedEli Lilly and Company12025-07-212026-09-21
Clinical Trial on Digestive Enzymes: Effects on Post-Meal Response to High-Macronutrient Meals
Digestive Enzyme Blend, Placebo - Gastrointestinal Digestion, Healthy
Phase 2CompletedPancap Pharma Inc.242025-07-112026-05-01
Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults
LVT-001, Cormirnaty - Healthy
Phase 1 / Phase 2RecruitingANRS, Emerging Infectious Diseases2382025-05-092025-12-18
Long-Term PEA Safety Study
Palmitoylethanolamide (PEA), Placebo - Healthy, Safety
Phase 2Active not recruitingRDC Clinical Pty Ltd2002025-01-222026-09-09
Comparison of the Effect of Red Wine With Alcohol on Flow-mediated Dilation Versus Red Wine Without Alcohol
red wine with alcohol, red wine without alcohol - Healthy, Healthy Diet
Phase 1 / Phase 2UnknownInstituto de Cardiologia de Santa Catarina152024-08-132024-08-16
Effects of an Antioxidant Supplement on Blood Vessel Health
MitoQ, Placebo, MitoTempo - Healthy
Phase 2RecruitingUniversity of Georgia602024-07-012024-12-09
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
NG101, Placebo, Semaglutide Injectable Product - Overweight and Obesity, Healthy
Phase 2CompletedNeurogastrx, Inc.1202024-06-242025-09-04

Showing 20 of 306. Sign in to see all of them.

Narrower conditions

Inflammation (7)  ·  Motor Activity (6)  ·  Influenza, Human (5)  ·  Obesity (5)  ·  Pain (5)  ·  Asthma (4)  ·  COVID-19 (4)  ·  Overweight (4)  ·  Acquired Immunodeficiency Syndrome (3)  ·  Cardiovascular Diseases (3)  ·  Coronary Artery Disease (3)  ·  Multiple Endocrine Neoplasia Type 1 (3)  ·  Acute Pain (2)  ·  Agnosia (2)  ·  Alzheimer Disease (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (35)  ·  Signs and Symptoms (24)  ·  Infections (22)  ·  Nutritional and Metabolic Diseases (19)  ·  Respiratory Tract Diseases (17)  ·  Mental Disorders (15)  ·  RNA Virus Infections (15)  ·  Virus Diseases (15)  ·  Metabolic Diseases (14)  ·  Nervous System Diseases (14)  ·  Behavior (13)  ·  Pathologic Processes (13)  ·  Brain Diseases (11)  ·  Central Nervous System Diseases (11)  ·  Neurologic Manifestations (11)

Interventions

Sodium Chloride (9)  ·  Magnetic Resonance Spectroscopy (5)  ·  PER977 (5)  ·  Psilocybin (4)  ·  Saline Solution (4)  ·  Aluminum Hydroxide (3)  ·  Capsaicin (3)  ·  Dexmedetomidine (3)  ·  Estradiol (3)  ·  Exercise (3)  ·  Injections (3)  ·  Resistance Training (3)  ·  Ropivacaine (3)  ·  Testosterone (3)  ·  acyline (3)

Sponsors

Janssen Vaccines & Prevention B.V. (9)  ·  Boehringer Ingelheim (8)  ·  MedImmune LLC (7)  ·  Massachusetts General Hospital (6)  ·  Johns Hopkins University (5)  ·  Mayo Clinic (5)  ·  National Heart, Lung, and Blood Institute (NHLBI) (5)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (5)  ·  University of Michigan (5)  ·  University of Washington (5)  ·  Beth Israel Deaconess Medical Center (4)  ·  National Institute of Mental Health (NIMH) (4)  ·  PT Bio Farma (4)  ·  Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. (4)  ·  Unity Health Toronto (4)

Countries

United States (156)  ·  Canada (25)  ·  United Kingdom (9)  ·  Australia (7)  ·  Denmark (7)  ·  France (7)  ·  Germany (7)  ·  Switzerland (7)  ·  Brazil (6)  ·  Israel (6)  ·  Sweden (6)  ·  Belgium (5)  ·  Indonesia (5)  ·  Japan (5)  ·  Netherlands (5)

Top investigators

David Crowley, MD (3)  ·  Stephanie T Page, MD, PhD (3)  ·  Yoghatama Cindya Zanzer, MSc (3)  ·  Abby C. King, PhD (2)  ·  Alexander Ehlgen, MD, PhD (2)  ·  Ali Khamesipour (2)  ·  Frederick S Barrett, PhD (2)  ·  Jakob H Andersen, MD (2)  ·  Jane Huggins, PhD (2)  ·  Janet E Hall, M.D. (2)  ·  Jeffery A Dusek, PhD (2)  ·  Muhammad N Aslam (2)

Results publications

PMID 23811290, PMID 11321442, PMID 11581560, PMID 12213959, PMID 12425704, PMID 16476851, PMID 16973674, PMID 17179457, PMID 17187586, PMID 17489364, PMID 17650319, PMID 17662149, PMID 19549740, PMID 20133465, PMID 20351373, PMID 20428452, PMID 20920070, PMID 21035624, PMID 21177791, PMID 21403877, PMID 21513761, PMID 21782874, PMID 21797916, PMID 21887214, PMID 22049179, PMID 22108775, PMID 22173804, PMID 22225857, PMID 22266332, PMID 22318394, PMID 22412063, PMID 22799482, PMID 23174266, PMID 23364679, PMID 23400744, PMID 23410167, PMID 23602668, PMID 23609341, PMID 23652021, PMID 24184488, PMID 24204744, PMID 24244025, PMID 24473536, PMID 24905063, PMID 25061716, PMID 25173483, PMID 25218298, PMID 25297058, PMID 25332827, PMID 25446328

NIH funding

2014 (2), R01AG013241 (2), R21HD054697 (2), 2008 (1), 2009 (1), 2016 (1), 2017 (1), 2023 (1), K23AG027238 (1), K23HL146887 (1), KL2RR024130 (1), P01DK068055 (1), P01HL158507 (1), R01AG016587 (1), R01AG019339 (1)